RK

Ritu Kaile

Active Director Director DIN 07329665
DIN 07329665 First appointment Oct 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2015
Shareholding value •••• Premium profile

About Ritu Kaile

Data last updated:

Ritu Kaile is a Director at Perk Pharmaceuticals Limited (since 2015). The company operates in Pharma. Perk Pharmaceuticals Limited reported revenue of ₹15.71 Cr (FY 2020).

DIN 07329665
Primary Designation Director
Industry Pharma
First Appointment 21 Oct 2015
Oldest Company Age 45 yrs
Largest company Perk Pharmaceuticals Limited · ₹15.71 Cr (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Perk Pharmaceuticals Limited L24231UP1981PLC005400
Director21 Oct 20151981₹15.71 Cr (FY 2020)Active

Board colleagues of Ritu Kaile

NameDINCompanyDesignation
Krishna Kaile00987703Perk Pharmaceuticals LimitedManaging Director
Monica Kaile07329652Perk Pharmaceuticals LimitedDirector

Directorship timeline

Open interactive timeline →
Perk Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Ritu Kaile

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritu Kaile

Ritu Kaile currently holds 1 directorship: Perk Pharmaceuticals Limited (Director, since 21 Oct 2015, revenue ₹15.71 Cr (FY 2020)).

Ritu Kaile was first appointed on 21 Oct 2015 as Director at Perk Pharmaceuticals Limited.

The current boards of Ritu Kaile's companies include Krishna Kaile (Perk Pharmaceuticals Limited), Monica Kaile (Perk Pharmaceuticals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available